4526 — Riken Vitamin Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesConservativeMid CapSuper Stock

Annual income statement for Riken Vitamin Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	R2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho/A	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	89,024	82,974	77,722	79,231	88,750
Cost of Revenue
Gross Profit	26,367	26,379	22,011	25,565	27,244
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	84,754	89,590	78,546	73,651	81,642
Operating Profit	4,270	-6,616	-824	5,580	7,108
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	5,180	-6,979	-7	20,313	7,857
Provision for Income Taxes
Net Income After Taxes	3,110	-8,883	-1,610	21,598	6,417
Minority Interest
Net Income Before Extraordinary Items
Net Income	3,086	-8,932	-1,618	21,582	6,414
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	3,085	-8,933	-1,618	21,582	6,414
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	94.8	-36.1	-5.83	663	197
Dividends per Share
Special Dividends per Share